Cargando…

Magnetic PiezoBOTs: a microrobotic approach for targeted amyloid protein dissociation

Piezoelectric nanomaterials have become increasingly popular in the field of biomedical applications due to their high biocompatibility and ultrasound-mediated piezocatalytic properties. In addition, the ability of these nanomaterials to disaggregate amyloid proteins, which are responsible for a ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Shen, Sanchis-Gual, Roger, Franco, Carlos, Wendel-Garcia, Pedro D., Ye, Hao, Veciana, Andrea, Tang, Qiao, Sevim, Semih, Hertle, Lukas, Llacer-Wintle, Joaquin, Qin, Xiao-Hua, Zhu, Caihong, Cai, Jun, Chen, Xiangzhong, Nelson, Bradley J., Puigmartí-Luis, Josep, Pané, Salvador
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517098/
https://www.ncbi.nlm.nih.gov/pubmed/37646185
http://dx.doi.org/10.1039/d3nr02418k
Descripción
Sumario:Piezoelectric nanomaterials have become increasingly popular in the field of biomedical applications due to their high biocompatibility and ultrasound-mediated piezocatalytic properties. In addition, the ability of these nanomaterials to disaggregate amyloid proteins, which are responsible for a range of diseases resulting from the accumulation of these proteins in body tissues and organs, has recently gained considerable attention. However, the use of nanoparticles in biomedicine poses significant challenges, including targeting and uncontrolled aggregation. To address these limitations, our study proposes to load these functional nanomaterials on a multifunctional mobile microrobot (PiezoBOT). This microrobot is designed by coating magnetic and piezoelectric barium titanate nanoparticles on helical biotemplates, allowing for the combination of magnetic navigation and ultrasound-mediated piezoelectric effects to target amyloid disaggregation. Our findings demonstrate that acoustically actuated PiezoBOTs can effectively reduce the size of aggregated amyloid proteins by over 80% in less than 10 minutes by shortening and dissociating constituent amyloid fibrils. Moreover, the PiezoBOTs can be easily magnetically manipulated to actuate the piezocatalytic nanoparticles to specific amyloidosis-affected tissues or organs, minimizing side effects. These biocompatible PiezoBOTs offer a promising non-invasive therapeutic approach for amyloidosis diseases by targeting and breaking down protein aggregates at specific organ or tissue sites.